Role of Stem Cells in Cardiac Diseases
Journal Title: International Journal of Stem Cell Research and Transplantation (IJST) - Year 2016, Vol 4, Issue 3
Abstract
Ischemic heart disease is the leading cause of global mortality, and cardiovascular diseases represent a major challenge for researchers because of the overall health complications associated with them. Numerous studies have shown that it is exceedingly difficult to induce cardiomyocytes to divide, resulting in a flood of interest in attempting to treat cardiac ischemia through the delivery of new cardiomyocytes. To do so, researchers have started investigating the potential of using induced pluripotent stem cells (iPS) to derive functional cardiomyocytes. The diverse cells that compose the heart and the subdivision of cardiomyocytes make it difficult to generate specific cells with specific genetic and functional signatures. Hence, it is essential to define the cardiac progenitor cells’ identity and subsequently design the best strategy to differentiate them into the appropriate mature functional cells.Recent studies in animal models and some clinical trials have shown the beneficial effects of these iPS cells in decreasing morbidity and improving heart function. Yet, many hurdles still need to be overcome before generalizing the conclusions reached so far. These are related to the nature of the manipulated cells, their delivery into the host, and their interaction with the host cells. This review touches upon the current knowledge of Cardiac Progenitor Cells (CPC), the role of iPS cells in understanding cardiac disease, as well as the clinical trials and animal models involving stem cells and cardiac disease
Authors and Affiliations
Georges Nemer
Keywords
Related Articles
- EP ID EP198008
- DOI 10.19070/2328-3548-1600028
- Views 87
- Downloads 0
Intravitreal Bevacizumab Followed by Ranibizumab for Neovascular Age Related Macular Degeneratıon
Purpose: To compare the outcomes after switching from intravitreal bevacizumab (IVB) to intravitreal ranibizumab (IVR) in patients with neovascular age related macular degeneration (ARMD). Material and Methods: A retrosp...
Effect of Snake Venom Disintegrin like domain on the Homing of Mesenchymal Stem Cells
Mesenchymal stem cells have many advantages as grafts for cell transplantation. The homing of MSCs after systemic infusion is still poorly understood. This report explored the effect of the combination of BM-MSCs with Di...
Re-Engraftment of Prior Cord Blood Graft in a Patient with Relapsed/Refractory Acute Myeloid Leukaemia following Haploidentical Transplantation
We report the case of a 32-year-old man with poor risk acute myeloid leukemia (AML) who received transplantation of an UCB graft following myeloablative conditioning but unfortunately relapsed after one year with complet...
Renal Transplantation from Donation After Circulatory Death Donors: Evolution of Strategies
Renal Transplantation from Donation After Circulatory Death Donors: Evolution of Strategies
Cancer Stem- Like Cells in Melanoma Progression, Resistance and Recurrence: Significance for Melanoma Treatment
Human malignant melanoma is a highly aggressive tumor which demonstrates heterogeneity and a propensity to drug resistance. Despite improved treatment options, patients with advanced malignant melanoma continue have a po...